Abstract
Phosphoflow analysis of T-cell activation signaling pathways. Flow cytometric measurements of ERK (pT202/204), p38 (pT180/y182), STAT3 (pY705), and STAT5 (pY694) phosphorylation were performed at baseline and after activation with PMA 40 nM (pERK and p38 analyses), IL-2 50 ng/mL (pSTAT5 analysis) or IL-6 20 ng/mL (pSTAT3 analysis) in the CD4+ and CD8+ T-cell subsets. Differences between post-activation/resting MFI ratios were examined in skin/joints scGVHD responder (C1D1: n=13; C2D1: n=13; C4D1: n=12) and non-responder (C1D1: n=7; C2D1: n=7; C4D1: n=5) patients in serial evaluations on day 1 of cycles 1, 2 and 4. MFI, median fluorescence intensity; n.s., non-statistically significant. *Omnibus Friedman test. No differences were detected in post-hoc tests.